Business
Hepatic Cirrhosis Market Research and Forecast Report 2026-2036, Profiles of Abbott, Astellas Pharma, Gilead Sciences, Novartis, Takeda Pharma, Grifols Therapeutics, and Cellaion
The global hepatic cirrhosis market is expanding rapidly, fueled by increasing liver disease cases, advanced treatment options, and improved healthcare infrastructure. Conditions like hepatitis, alcohol abuse, and metabolic dysfunction-associated steatotic liver disease (MASLD) are elevating cirrhosis prevalence, especially in regions with factors like high alcohol consumption. Innovative treatments, including antiviral drugs and antifibrotic agents, are gaining traction, though challenges such
About this update from Abbott Laboratories
[{"type":"image","alt":"Company Logo","displaySize":"","headline":null,"caption":"Company Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":36,"url":"https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/LAb6sww2pvOwp1YOuMHMug--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTUw/https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65","width":300,"height":36},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/LAb6sww2pvOwp1YOuMHMug--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTUw/https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65","width":300,"height":36}},"lazy":false},{"type":"text","content":"The global hepatic cirrhosis market is expanding rapidly, fueled by increasing liver disease cases, advanced treatment options, and improved healthcare infrastructure. Conditions like hepatitis, alcohol abuse, and metabolic dysfunction-associated steatotic liver disease (MASLD) are elevating cirrhosis prevalence, especially in regions with factors like high alcohol consumption. Innovative treatments, including antiviral drugs and antifibrotic agents, are gaining traction, though challenges such as high costs and inadequate awareness persist. North America leads the market, but Asia-Pacific shows the fastest growth. Key players like Gilead Sciences and Novartis are driving advancements through strategic collaborations and acquisitions.","length":744,"tagName":"p"},{"type":"text","content":"Dublin, May 18, 2026 (GLOBE NEWSWIRE) -- The "Hepatic Cirrhosis Market - A Global and Regional Analysis: Focus on Disease Type, Treatment, Country, 2026-2036" report has been added to ResearchAndMarkets.com's offering.The global hepatic cirrhosis market is experiencing notable growth, driven by increasing cases of liver diseases, advancements in treatment options, and improving healthcare infrastructure worldwide.","length":434,"tagName":"p"},{"type":"text","content":"The market is witnessing a surge in innovative therapies, including antiviral drugs for hepatitis-induced cirrhosis, immunosuppressants for autoimmune-related cirrhosis, and antifibrotic agents aimed at reducing liver fibrosis. These treatments are providing new hope for patients, especially with liver transplantation becoming a critical option for those with...